Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

Clinical trial NCT05589207 · RECRUITING

Trial details

NCT number: NCT05589207
Sponsor: Peking University Third Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Carcinoma, Renal Cell Tumor Thrombus Neoplasm Invasiveness Inferior Vena Cava Interruption

Start date: 2023-01-01
Primary completion: 2026-01-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.